致癌 KRAS 依赖性基质白细胞介素 33 指导胰腺微环境促进肿瘤生长。
Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth.
发表日期:2024 Jul 03
作者:
Katelyn L Donahue, Hannah R Watkoske, Padma Kadiyala, Wenting Du, Kristee Brown, Michael K Scales, Ahmed M Elhossiny, Carlos E Espinoza, Emily L Lasse Opsahl, Brian D Griffith, Yukang Wen, Lei Sun, Ashley Velez-Delgado, Nur M Renollet, Jacqueline Morales, Nicholas M Nedzesky, Rachael K Baliira, Rosa E Menjivar, Paola I Medina-Cabrera, Arvind Rao, Benjamin Allen, Jiaqi Shi, Timothy L Frankel, Eileen S Carpenter, Filip Bednar, Yaqing Zhang, Marina Pasca di Magliano
来源:
CYTOKINE & GROWTH FACTOR REVIEWS
摘要:
胰腺癌的特点是广泛的纤维炎症微环境。在癌发生过程中,正常基质细胞转化为细胞因子高的癌症相关成纤维细胞(CAF)。这种转化的机制,包括成纤维细胞衍生的细胞因子的调节和功能,人们知之甚少。因此,迄今为止,针对 CAF 进行治疗的努力都失败了。在这里,我们发现来自表达致癌 KRAS(胰腺癌标志性突变)的上皮细胞发出的信号激活成纤维细胞自分泌信号,从而驱动细胞因子白细胞介素 33 (IL-33) 的表达。在整个癌变过程中,间质 IL-33 表达保持高水平并依赖于上皮 KRAS;反过来,环境压力会诱导 IL-33 分泌。使用区室特异性 IL-33 敲除小鼠,我们观察到基质 IL-33 的缺乏会导致胰腺肿瘤微环境的多个成分(包括 CAF、骨髓细胞和淋巴细胞)发生深刻的重编程。值得注意的是,基质 IL-33 的缺失会导致 CD8 T 细胞浸润和激活增加,并最终减少肿瘤生长。
Pancreatic cancer is characterized by an extensive fibroinflammatory microenvironment. During carcinogenesis, normal stromal cells are converted to cytokine-high cancer associated fibroblasts (CAFs). The mechanisms underlying this conversion, including regulation and function of fibroblast-derived cytokines, are poorly understood. Thus, efforts to target CAFs therapeutically have so far failed. Here, we show that signals from epithelial cells expressing oncogenic KRAS -a hallmark pancreatic cancer mutation- activate fibroblast autocrine signaling, which drives expression of the cytokine interleukin-33 (IL-33). Stromal IL-33 expression remains high and dependent on epithelial KRAS throughout carcinogenesis; in turn, environmental stress induces IL-33 secretion. Using compartment-specific IL-33 knockout mice, we observed that lack of stromal IL-33 leads to profound reprogramming of multiple components of the pancreatic tumor microenvironment, including CAFs, myeloid cells and lymphocytes. Notably, loss of stromal IL-33 leads to an increase in CD8+ T cell infiltration and activation, and, ultimately, reduced tumor growth.